Targeted Therapies in Cancer Myth or Reality? /
No BCC for this title.
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic eBook |
Language: | English |
Published: |
New York, NY :
Springer New York,
2008.
|
Series: | Advances in Experimental Medicine and Biology,
610 |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Causality in Medicine
- The Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy
- Anticancer Drug Discovery and Development
- Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms
- Aurora Kinases and Their Inhibitors: More Than One Target and One Drug
- Signalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors
- Developing T-Cell Therapies for Cancer in an Academic Setting
- Anticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells
- Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies
- Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned?
- GIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design
- Monoclonal Antibodies in the Treatment of Malignant Lymphomas
- Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy.